Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.470 USD | +1.18% |
|
-6.42% | +1.50% |
Feb. 10 | CVS Health Fiscal 2025 EPS Outlook Seen Lower on Health Care Benefits Segment, UBS Says | MT |
Feb. 07 | Walgreens Boots Alliance Cuts Stake in Cencora to About 6% | MT |
Fiscal Period: August | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 456M | 2.54B | 4.34B | -3.08B | -8.64B | |||||
Depreciation & Amortization - CF | 1.15B | 1.17B | 1.04B | 1.07B | 1.08B | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 461M | 523M | 639M | 815M | 963M | |||||
Depreciation & Amortization, Total | 1.61B | 1.69B | 1.68B | 1.89B | 2.04B | |||||
Amortization of Deferred Charges, Total - (CF) | 314M | 284M | 307M | 371M | 414M | |||||
(Gain) Loss on Sale of Investments - (CF) | - | -321M | -2.9B | -1.86B | -1.16B | |||||
Asset Writedown & Restructuring Costs | 2.02B | 49M | 834M | 1.29B | 14.37B | |||||
(Income) Loss On Equity Investments - (CF) | -382M | 498M | -468M | -286M | -230M | |||||
Stock-Based Compensation (CF) | 137M | 155M | 391M | 385M | 182M | |||||
Net Cash From Discontinued Operations | - | -322M | - | - | - | |||||
Other Operating Activities, Total | 389M | 553M | -778M | -3.9B | -5.48B | |||||
Change In Accounts Receivable | 163M | -1.45B | 808M | 72M | -464M | |||||
Change In Inventories | 63M | 165M | -433M | 287M | -31M | |||||
Change In Accounts Payable | -25M | 842M | 244M | 1.24B | 1.41B | |||||
Change In Income Taxes | -221M | 160M | -51M | 441M | 30M | |||||
Change in Other Net Operating Assets | 961M | 712M | -73M | 5.4B | -1.43B | |||||
Cash from Operations | 5.48B | 5.56B | 3.9B | 2.26B | 1.02B | |||||
Capital Expenditure | -1.37B | -1.38B | -1.73B | -2.12B | -1.38B | |||||
Cash Acquisitions | -718M | -1.43B | -2.19B | -7.31B | -402M | |||||
Divestitures | - | 5.53B | - | - | - | |||||
Investment in Marketable and Equity Securities, Total | - | - | - | - | - | |||||
Other Investing Activities, Total | 795M | 1.36B | 2.86B | 6.34B | 3.66B | |||||
Cash from Investing | -1.3B | 4.07B | -1.06B | -3.09B | 1.88B | |||||
Short Term Debt Issued, Total | - | - | - | - | - | |||||
Long-Term Debt Issued, Total | 20.37B | 12.73B | 11.96B | 6.28B | 31.36B | |||||
Total Debt Issued | 20.37B | 12.73B | 11.96B | 6.28B | 31.36B | |||||
Short Term Debt Repaid, Total | -161M | -909M | -11M | -1M | -2M | |||||
Long-Term Debt Repaid, Total | -21.41B | -18.94B | -9.95B | -8.98B | -30.79B | |||||
Total Debt Repaid | -21.58B | -19.85B | -9.96B | -8.98B | -30.79B | |||||
Issuance of Common Stock | 55M | 59M | 27M | 45M | - | |||||
Repurchase of Common Stock | -1.59B | -110M | -187M | -150M | -69M | |||||
Common Dividends Paid | -1.75B | -1.62B | -1.66B | -1.66B | -1.26B | |||||
Common & Preferred Stock Dividends Paid | -1.75B | -1.62B | -1.66B | -1.66B | -1.26B | |||||
Other Financing Activities, Total | -158M | -241M | -1.68B | 3.58B | 220M | |||||
Cash from Financing | -4.65B | -9.04B | -1.5B | -887M | -538M | |||||
Foreign Exchange Rate Adjustments | -1M | -66M | -47M | 20M | 4M | |||||
Miscellaneous Cash Flow Adjustments | 1M | -1M | -1M | 1M | - | |||||
Net Change in Cash | -460M | 524M | 1.29B | -1.7B | 2.36B | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 584M | 916M | 420M | 606M | 578M | |||||
Cash Income Tax Paid (Refund) | 600M | 336M | 387M | 64M | 297M | |||||
Levered Free Cash Flow | 3.35B | 2.75B | 2.87B | 2.62B | 2.73B | |||||
Unlevered Free Cash Flow | 3.72B | 3.07B | 3.14B | 2.99B | 3.1B | |||||
Change In Net Working Capital | -1.16B | -14M | -960M | -1.66B | -1.31B | |||||
Net Debt Issued / Repaid | -1.21B | -7.13B | 2B | -2.7B | 571M |